Transverse leukonychia following chemotherapy in a patient with Hodgkin's disease.
Nail changes often represent diagnostic hallmarks for a variety of systemic diseases. The awareness of drug-induced nail injuries is important in order to avoid unnecessary diagnostic activities. We observed a 21-year-old female patient with Hodgkin's lymphoma, who developed transverse leukonychia of all fingernails associated with polychemotherapy.
Naumann
R
R
Department of Medicine I and Department of Dermatology, University Hospital "Carl Gustav Carus", Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany. naumann@oncocenter.de
Wozel
G
G
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005385:Fingers; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced*; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone